Healthcare Nov 20, 2020 08:14 PM (GMT+8) · EqualOcean
On the 20th, Pfizer submitted an application for emergency use authorization of the new crown vaccine to the US FDA on Friday. It is understood that the approval of the EUA will take weeks. According to foreign media reports, a person familiar with the matter said that FDA's covid-19 Vaccine Advisory Committee is tentatively scheduled to meet from next month 8 to 10 to discuss the vaccine. Previously, Pfizer announced that the effectiveness analysis of its new crown candidate vaccine trials had been completed, and the data showed that the vaccine had 95% effectiveness.